Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy

Cancer

Volumn 81, Issue 6, 1997, Pages 354-364

  Katz, Ruth L ^a   Sinkre, Prasanna A ^a   Zhang, Hua Hung ^a   Kidd, Larry ^a   Johnston, Dennis ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cystoscopy; DNA ploidy; Image analysis; Urine cytology; Urothelial carcinoma

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PLOIDY; PREDICTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOGISTIC MODELS; MALE; MIDDLE AGED; PLOIDIES; PREDICTIVE VALUE OF TESTS; URINARY BLADDER NEOPLASMS; URINE;

EID: 0031586627     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971225)81:6<354::AID-CNCR10>3.0.CO;2-Y     Document Type: Article

References (16)

1. Meier U, Simak R, Neuhold N. The clinical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol 1995;48:314-7.
2. Koss LG. Tumors of the urinary tract and prostate in urinary sediment. In: Diagnostic cytology and its histopathologic bases. 4th edition. Volume 2. Philadelphia: J.B. Lippincott, 1992:934-1017.
3. Borchers H, Planz B, Jakse G, Boking A. DNA aneuploidy in G1-urothelial carcinomas of the urinary bladder. Urol Int 1994;52:145-50.
4. Bonner RB, Hemstreet GP 3rd, Fradet Y, Rao JY, Min KW, Hurst RE. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells. Cancer 1993;72:2461-9.
5. Shabaik AS, Pow-Sang JM, Lockhart J, Nicosia SV. Role of DNA image cytometry in follow-up of patients with urinary tract transitional cell carcinoma. Anal Quant Cytol Histol 1993;15(2):115.
6. De la Roza G, Hopkovitz A, Caraway NP, Kidd L, Dinney CP, Johnston D. DNA IA of urinary cytology: prediction of recurrent transitional cell carcinoma. Mod Pathol 1996;9:571-8.
7. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. In: International histological classification of tumors. No. 10. Geneva: World Health Organization, 1973:x-x.
8. Hosmen DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc., 1989.
9. Lee ET. Statistical methods for survival data analysis. 2nd edition. New York: John Wiley & Sons, Inc., 1992.
10. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. Acta Cytol 1993;37:115-4.
11. D'Hallewin M-A, Baert L. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 1996;155:475-576.
12. Soloway MS, Briggman JV, Carpinito GA, Chodak GW, Church PA, et al. Use of a new tumor marker, urinary NMP 22, in the detection of occult or rapidly recurring TCC of the urinary tract following surgical treatment. J Urol 1996;156:363-7.
13. Soloway MS, Murphy WM, Rao MK, Cox C. Serial multiple site biopsies in patients with bladder cancer. J Urol 1978;120:56-9.
14. Allegra SR, Fanning JP, Streker JF, Corvese NM. Cytologic diagnosis of occult and in situ carcinoma of the urinary system. Acta Cytol 1966;10:340.
15. Katz RL, Wagner S, Zhang H, Kidd L, Dinny C, Grossman B. Significance of numerical chromosomal abnormalities (NCA) in bladder washes (BW) from transitional cell carcinoma (TCC) in patients with cytoscopically normal bladder mucosa. Mod Pathol 1996;9:35A.
16. Cajulis RS, Haines GK III, Frias Hidvegi D, McVary K. Interphase cytogenetics as an adjunct in the cytodiagnoses of urinary bladder carcinomas. Anal Quant Cytol Histol 1994;6:1-10.